Milestones in Personalized Medicine: From the Ancient Time to Nowadays—the Provocation of COVID-19
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Milestones in Personalized Medicine: From the Ancient Time to Nowadays—the Provocation of COVID-19
Authors
Keywords
-
Journal
Frontiers in Genetics
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-11-30
DOI
10.3389/fgene.2020.569175
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development and Clinical Application of A Rapid IgM‐IgG Combined Antibody Test for SARS‐CoV‐2 Infection Diagnosis
- (2020) Zhengtu Li et al. JOURNAL OF MEDICAL VIROLOGY
- Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases
- (2020) Tao Ai et al. RADIOLOGY
- Of chloroquine and COVID-19
- (2020) Franck Touret et al. ANTIVIRAL RESEARCH
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19
- (2020) Zhen Zhu et al. JOURNAL OF INFECTION
- Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19
- (2020) Jahan S. Khalili et al. JOURNAL OF MEDICAL VIROLOGY
- Tocilizumab treatment in COVID-19: A single center experience
- (2020) Pan Luo et al. JOURNAL OF MEDICAL VIROLOGY
- Developing antibody tests for SARS-CoV-2
- (2020) Anna Petherick LANCET
- Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
- (2020) Nicola Principi et al. LANCET INFECTIOUS DISEASES
- Lopinavir–ritonavir in severe COVID-19
- (2020) Hannah Stower NATURE MEDICINE
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- (2020) Jianjun Gao et al. BioScience Trends
- Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?
- (2020) Giuseppe Lippi et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19
- (2020) Andrea Cortegiani et al. JOURNAL OF CRITICAL CARE
- The network effect: studying COVID-19 pathology with the Human Cell Atlas
- (2020) Sarah Teichmann et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Genomewide Association Study of Severe Covid-19 with Respiratory Failure
- (2020) David Ellinghaus et al. NEW ENGLAND JOURNAL OF MEDICINE
- Progress in Polygenic Composite Scores in Alzheimer’s and Other Complex Diseases
- (2019) Danai Chasioti et al. TRENDS IN GENETICS
- Heme Catabolic Pathway in Inflammation and Immune Disorders
- (2019) Bing Wu et al. Frontiers in Pharmacology
- Malaria: The Past and the Present
- (2019) Talapko et al. Microorganisms
- Favism and Glucose-6-Phosphate Dehydrogenase Deficiency
- (2018) Lucio Luzzatto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing
- (2017) Yao Yang et al. PHARMACOGENOMICS
- Biomarkers and personalized medicine: current status and further perspectives with special focus on dermatology
- (2016) Lilla Landeck et al. EXPERIMENTAL DERMATOLOGY
- Ten years of anti-vascular endothelial growth factor therapy
- (2016) Napoleone Ferrara et al. NATURE REVIEWS DRUG DISCOVERY
- The Value of Companion Diagnostics: Overcoming Access Barriers to Transform Personalised Health Care into an Affordable Reality in Europe
- (2016) Victoria Wurcel et al. Public Health Genomics
- Pharmacogenomics in the clinic
- (2015) Mary V. Relling et al. NATURE
- Vascular Endothelial Growth Factor Signaling in Hypoxia and Inflammation
- (2014) S. Ramakrishnan et al. Journal of Neuroimmune Pharmacology
- Primaquine: the risks and the benefits
- (2014) Elizabeth A Ashley et al. MALARIA JOURNAL
- Anti-vascular endothelial growth factor therapy in the era of personalized medicine
- (2013) Luis R. Féliz et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Personalized medicine: challenges and opportunities for translational bioinformatics
- (2013) Casey Lynnette Overby et al. Personalized Medicine
- Personalized Medicine: Potential, Barriers and Contemporary Issues
- (2012) Michael J. Sorich et al. CURRENT DRUG METABOLISM
- HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies
- (2011) Devika Gajria et al. Expert Review of Anticancer Therapy
- Biomarkers and Heart Disease
- (2011) Michelle A. Albert Journal of Clinical Sleep Medicine
- Adjuvant Trastuzumab in HER2-Positive Breast Cancer
- (2011) Dennis Slamon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Personalized therapy and pharmacogenomics: future perspective
- (2009) Gérard Siest et al. PHARMACOGENOMICS
- Pharmacogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacity
- (2008) Adrián LLerena et al. PHARMACOGENOMICS
- Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6-drug interactions
- (2007) J-D Maréchal et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search